Haleon PLC (GB:HLN) has released an update.
Haleon PLC successfully conducted its 2024 Annual General Meeting, with all resolutions passed, including special resolutions on various corporate matters. Key decisions included the approval of the Annual Report & Accounts, Directors’ Remuneration Report, and the re-election of board members, reflecting shareholders’ high confidence in the company’s leadership and direction. The company, renowned for its leading consumer health products like Advil and Sensodyne, continues to focus on delivering better everyday health to consumers worldwide.
For further insights into GB:HLN stock, check out TipRanks’ Stock Analysis page.
